Latest | F'cast | |
---|---|---|
Div Yield | 2.4% | |
Div Cover | 0.0 | |
Op Mrgn | 3.1% | |
ROCE | 5.6% |
Latest | F'cast | |
---|---|---|
P/E | 896.7 | |
PEG | n/a | |
Pr/Revenue | 5.3 | |
Pr/Book | 8.4 |
Latest | F'cast | |
---|---|---|
Revenue | 1.4% | |
PBT | -88.5% | |
EPS | -97.6% | |
DPS | 5.7% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-19 | 46,840.00 | 11,464.00 | 384.00¢ | 23.7 | 0.4 | +64% | 226.00¢ | 2.5% |
31-Dec-20 | 47,994.00 | 8,791.00 | 179.00¢ | 45.7 | n/a | -53% | 248.00¢ | 3.0% |
31-Dec-21 | 48,704.00 | 13,879.00 | 488.00¢ | 15.7 | 0.1 | +173% | 264.00¢ | 3.4% |
31-Dec-22 | 59,283.00 | 16,444.00 | 573.00¢ | 19.4 | 1.1 | +17% | 280.00¢ | 2.5% |
31-Dec-23 | 60,115.00 | 1,889.00 | 14.00¢ | 778.7 | n/a | -98% | 296.00¢ | 2.7% |
Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-24 | 64,262.16 | 26,095.84 | 865.67¢ | 14.5 | 0.0 | +6,083% | 322.20¢ | 0.0% |
31-Dec-25 | 69,031.96 | 29,848.04 | 998.87¢ | 12.6 | 0.8 | +15% | 345.66¢ | 0.0% |
31-Dec-26 | 73,221.59 | 32,492.77 | 1,098.37¢ | 11.4 | 1.1 | +10% | 369.94¢ | 0.0% |
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
Merck to buy EyeBio for up to $3bn | 29-May-2024 | ShareCast |
US close: Stocks recover from three days of losses | 28-Mar-2024 | ShareCast |
US close: Stocks bounce back as labour market so... | 02-Feb-2024 | ShareCast |
Currency | US Dollars |
Share Price | $ 125.54 |
Change Today | $ 1.01 |
% Change | 0.81 % |
52 Week High | $131.95 |
52 Week Low | $100.18 |
Volume | 18,150,361 |
Shares Issued | 2,531.63m |
Market Cap | $317,821m |
RiskGrade | 92 |
Strong Buy | 11 |
Buy | 12 |
Neutral | 3 |
Sell | 0 |
Strong Sell | 0 |
Total | 26 |
Time | Volume / Share Price |
15:59 | 100 @ $125.64 |
15:59 | 600 @ $125.66 |
15:59 | 200 @ $125.66 |
15:59 | 240 @ $125.66 |
15:59 | 160 @ $125.65 |
You are here: research